GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com


Jump to: navigation, search

Cha, GH, Kim, S, Park, J, Lee, E, Kim, M, Lee, SB, Kim, JM, Chung, J and Cho, KS (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc. Natl. Acad. Sci. U.S.A. 102:10345-50


Parkin, an E3 ubiquitin ligase, has been found to be responsible for autosomal recessive juvenile parkinsonism characterized primarily by selective loss of dopaminergic neurons with subsequent defects in movements. However, the molecular mechanisms underlying this neuron loss remain elusive. Here, we characterized Drosophila parkin loss-of-function mutants, which exhibit shrinkage of dopaminergic neurons with decreased tyrosine hydroxylase level and impaired locomotion. The behavioral defect of parkin mutant flies was partially restored by administering L-DOPA, and the dopamine level in the brains of parkin mutant flies was highly decreased. Intriguingly, we found that c-Jun N-terminal kinase (JNK) is strongly activated in the dopaminergic neurons of parkin mutants and that impaired dopaminergic neuron phenotypes are dependent on the activation of the JNK signaling pathway. In consistent with this, our epistatic analysis and mammalian cell studies showed that Parkin inhibits the JNK signaling pathway in an E3 activity-dependent manner. These results suggest that loss of Parkin function up-regulates the JNK signaling pathway, which may contribute to the vulnerability of dopaminergic neurons in Drosophila parkin mutants and perhaps autosomal recessive juvenile parkinsonism patients.


PubMed PMC1177361 Online version:10.1073/pnas.0500346102


Animals; Blotting, Northern; Blotting, Western; Brain/metabolism; COS Cells; Cercopithecus aethiops; Dopamine/metabolism; Drosophila; Drosophila Proteins/genetics; Drosophila Proteins/metabolism; Histocytochemistry; Immunoenzyme Techniques; Immunoprecipitation; JNK Mitogen-Activated Protein Kinases/metabolism; Levodopa; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases/metabolism; Mutation/genetics; Neurons/metabolism; Parkinsonian Disorders/genetics; Parkinsonian Disorders/metabolism; Signal Transduction/physiology; Tyrosine 3-Monooxygenase/metabolism; Ubiquitin-Protein Ligases



Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status

See also


See Help:References for how to manage references in GONUTS.